{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:13Z","timestamp":1792507513122,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#303116\/2022-6"],"award-info":[{"award-number":["#303116\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>About 5\u201310% of patients with Sj\u00f6gren\u2019s Disease (SjD) will develop non-Hodgkin\u2019s lymphoma, with a 16 to 44 increased risk compared to the general population. The relationship between SjD and other types of cancer is poorly described in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To characterize patients with SjD from the Brazilian Sj\u00f6gren\u2019s Disease Registry (BRAS) who developed hematological and solid neoplasms, analyzing the organ primarily involved, subtypes, occurrence of metastatic disease, timing of diagnosis and correlation with demographic, serologic aspects, and labial salivary gland inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Among consecutive patients included in the Brazilian Sj\u00f6gren\u2019s Disease Registry (BRAS) and fulfilling the 2002 or 2016 classification criteria for SjD, those who developed neoplasia were retrospectively identified and categorized according to the National Cancer Institute (Ministry of Health, Brazil). RESULTS: 1,010 patients were included; of them, 975 were women (96.5%), with an average age of 55.6\u2009\u00b1\u200913.6 years. Disease duration was 11.9\u2009\u00b1\u20097.9 years. We found that 114 out of 1,010 patients (11.3%) had cancer, with a higher prevalence in those over 55 years old (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The most prevalent malignancies were skin cancer [24\/858 (2.7%)], breast cancer [27\/1010 (2.6%)], lymphoma [15\/1010 (1.5%)], and thyroid cancer [8\/1010 (0.8%)]. Further, 0.9% of patients had more than one type of cancer. Cancer diagnosis followed SjD diagnosis in 66.7% of lymphoma cases, 53.6% of other malignancies, and 75.0% of skin cancer. The presence of cancer was associated with age (OR 1.04). In the case of skin cancer, the duration of SjD was an additional risk factor (OR 1.08). For thyroid cancer, inflammation of the labial minor salivary glands was identified as an associated risk factor (OR 10.1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Other types of cancer were more prevalent than lymphoma in our population of SjD patients. Breast neoplasia emerged as the most prevalent after skin cancer, and thyroid cancer was the second most prevalent solid neoplasia. Aging, disease duration and labial salivary gland inflammation were associated risk factors. Prospective cohort studies are essential for assessing other risk factors for cancer development in SjD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-025-00470-7","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:01:59Z","timestamp":1755684119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of solid tumors and lymphoma in the Brazilian Sj\u00f6gren\u2019s Disease Registry (BRAS): an important concern for clinical practice"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-6285","authenticated-orcid":false,"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Reis","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Gofinet","family":"Pasoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"de Almeida\u00a0Pernambuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisson","family":"Pugliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Augusto","family":"Tanure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L\u00facia","family":"Lemos\u00a0Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysa C\u00e9sar","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiessa Zanchett","family":"Fedrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L\u00facia Euz\u00e9bio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Gatz","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna Sant\u2019Ana","family":"Petterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Ust\u00e1rroz","family":"Cantali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Coradin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Pafume","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty Lisie","family":"Libardi\u00a0Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00edssa Dudienas Domingues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Tatiyama","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Carvas\u00a0Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"470_CR1","unstructured":"Baer AN. Diagnosis and classification of Sj\u00f6gren\u2019s disease - UpToDate. https:\/\/www.uptodate.com\/contents\/diagnosis-and-classification-of-sjogrens-disease. Acessado em 06\/09\/2023."},{"issue":"1","key":"470_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9\u201325.","journal-title":"Clin Exp Med"},{"issue":"11","key":"470_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, et al. Epidemiology of primary sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"470_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S0482-50042013000100003","volume":"53","author":"V Valim","year":"2013","unstructured":"Valim V, Zandonade E, Pereira AM, et al. Primary sj\u00f6gren\u2019s syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol. 2013;53(1):24\u201334.","journal-title":"Rev Bras Reumatol"},{"key":"470_CR5","first-page":"247","volume":"6","author":"R Patel","year":"2014","unstructured":"Patel R, Shahane A. The epidemiology of sj\u00f6gren\u2019s syndrome. Clin Epidemiol. 2014;6:247\u201355.","journal-title":"Clin Epidemiol"},{"issue":"6","key":"470_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/art.40040","volume":"69","author":"KE Taylor","year":"2017","unstructured":"Taylor KE, Wong Q, Levine DM, et al. Genome-wide association analysis reveals genetic heterogeneity of sj\u00f6gren\u2019s syndrome according to ancestry. Arthritis Rheumatol. 2017;69(6):1294\u2013305.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"470_CR7","first-page":"234","volume":"37","author":"VM Harris","year":"2019","unstructured":"Harris VM, Scofield RH, Sivils KL. Genetics in sj\u00f6gren\u2019s syndrome: where we are and where we go. Clin Exp Rheumatol. 2019;37(3):234\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jsbmb.2014.08.014","volume":"145","author":"YT Konttinen","year":"2015","unstructured":"Konttinen YT, Stegajev V, Al-Samadi A, Porola P, Hietanen J, Ainola M. Sj\u00f6gren\u2019s syndrome and extragonadal sex steroid formation: a clue to a better disease control? J Steroid Biochem Mol Biol. 2015;145:237\u201344.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"470_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/BOR.0000000000000084","volume":"26","author":"SG Pasoto","year":"2014","unstructured":"Pasoto SG, Ribeiro AC, Bonfa E. Update on infections and vaccinations in systemic lupus erythematosus and sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol. 2014;26(5):528\u201337.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"470_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/ijms22020658","volume":"22","author":"C Chivasso","year":"2021","unstructured":"Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo MS. The involvement of innate and adaptive immunity in the initiation and perpetuation of sj\u00f6gren\u2019s syndrome. Int J Mol Sci. 2021;22(2):658.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"470_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/1744666X.2019.1649596","volume":"15","author":"S De Vita","year":"2019","unstructured":"De Vita S, Gandolfo S. Predicting lymphoma development in patients with sj\u00f6gren\u2019s syndrome. Expert Rev Clin Immunol. 2019;15(9):929\u201338.","journal-title":"Expert Rev Clin Immunol"},{"issue":"20","key":"470_CR12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337\u201344.","journal-title":"Arch Intern Med"},{"issue":"6","key":"470_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","volume":"73","author":"Y Liang","year":"2014","unstructured":"Liang Y, Yang Z, Qin B, Zhong R. Primary sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014;73(6):1151\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"470_CR14","doi-asserted-by":"publisher","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","volume":"21","author":"H Zhong","year":"2022","unstructured":"Zhong H, Liu S, Wang Y, et al. Primary sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis. Autoimmun Rev. 2022;21(5):103084.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"470_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"470_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American college of rheumatology\/european league against rheumatism classification criteria for primary sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35\u201345.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"470_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Med (Baltim). 2009;88(5):284\u201393.","journal-title":"Med (Baltim)"},{"issue":"7","key":"470_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","volume":"14","author":"A Papageorgiou","year":"2015","unstructured":"Papageorgiou A, Voulgarelis M, Tzioufas AG. Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome. Autoimmun Rev. 2015;14(7):641\u20139.","journal-title":"Autoimmun Rev"},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","volume":"104","author":"EK Kapsogeorgou","year":"2019","unstructured":"Kapsogeorgou EK, Voulgarelis M, Tzioufas AG. Predictive markers of lymphomagenesis in sj\u00f6gren\u2019s syndrome: from clinical data to molecular stratification. J Autoimmun. 2019;104:102316.","journal-title":"J Autoimmun"},{"issue":"9","key":"470_CR20","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/rheumatology\/keab939","volume":"61","author":"LG Chatzis","year":"2022","unstructured":"Chatzis LG, Stergiou IE, Goules AV, et al. Clinical picture, outcome and predictive factors of lymphoma in primary sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021). Rheumatology (Oxford). 2022;61(9):3576\u201385.","journal-title":"Rheumatology (Oxford)"},{"key":"470_CR21","unstructured":"Minist\u00e9rio da Sa\u00fade. Instituto Nacional de C\u00e2ncer. Estimativa 2023 \u2013 incid\u00eancia de c\u00e2ncer no Brasil. https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/\/media\/document\/\/estimativa-2023.pdf. Accessed on 9 August 2024."},{"issue":"7","key":"470_CR22","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10067-024-06993-6","volume":"43","author":"N Ansari","year":"2024","unstructured":"Ansari N, Salesi M. The association between primary sjogren\u2019s syndrome and non-Hodgkin\u2019s lymphoma: a systematic review and meta-analysis of cohort studies. Clin Rheumatol. 2024;43(7):2177\u201386.","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"470_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","volume":"39","author":"AG Tzioufas","year":"2012","unstructured":"Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of sjogren\u2019s syndrome: what we know and what we should learn. J Autoimmun. 2012;39(1\u20132):4\u20138.","journal-title":"J Autoimmun"},{"issue":"6","key":"470_CR24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s10067-020-04983-y","volume":"39","author":"LKN Guedes","year":"2020","unstructured":"Guedes LKN, Leon EP, Bocate TS, et al. Characterizing hand and wrist ultrasound pattern in primary sj\u00f6gren\u2019s syndrome: a case-control study. Clin Rheumatol. 2020;39(6):1907\u20138.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"470_CR25","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1111\/odi.14435","volume":"29","author":"W Saleh","year":"2023","unstructured":"Saleh W, Elashry MM, Winn N, Mona M, Katz J, Cha S. A lower prevalence of malignant lymphoma in sj\u00f6gren\u2019s syndrome patients: A cross-sectional study. Oral Dis. 2023;29(8):3313\u201324.","journal-title":"Oral Dis"},{"issue":"10","key":"470_CR26","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/art.42550","volume":"75","author":"PM Duret","year":"2023","unstructured":"Duret PM, Schleiss C, Kawka L, et al. Association between bruton\u2019s tyrosine kinase gene overexpression and risk of lymphoma in primary sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2023;75(10):1798\u2013811.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"470_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12865-024-00646-8","volume":"25","author":"Y Xu","year":"2024","unstructured":"Xu Y, Han J, Fan Z, Liang S. Transcriptomics explores potential mechanisms for the development of primary sjogren\u2019s syndrome to diffuse large B-cell lymphoma in B cells. BMC Immunol. 2024;25(1):53.","journal-title":"BMC Immunol"},{"issue":"5","key":"470_CR28","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/rheumatology\/key329","volume":"60","author":"JM Pego-Reigosa","year":"2021","unstructured":"Pego-Reigosa JM, Restrepo V\u00e9lez J, Baldini C. R\u00faa-Figueroa Fern\u00e1ndez de Larrinoa \u00cd. Comorbidities (excluding lymphoma) in sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60(5):2075\u201384.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"470_CR29","doi-asserted-by":"publisher","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","volume":"20","author":"R Goulabchand","year":"2021","unstructured":"Goulabchand R, Malafaye N, Jacot W, et al. Cancer incidence in primary sj\u00f6gren\u2019s syndrome: data from the French hospitalization database. Autoimmun Rev. 2021;20(12):102987.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"470_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","volume":"10","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n P, Kostov B, Fraile G, et al. Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome. J Hematol Oncol. 2017;10(1):90.","journal-title":"J Hematol Oncol"},{"issue":"Suppl 126","key":"470_CR31","first-page":"40","volume":"38","author":"JK Ahn","year":"2020","unstructured":"Ahn JK, Hwang J, Seo GH. Risk of non-Hodgkin\u2019s lymphoma and thyroid cancer in primary sj\u00f6gren\u2019s syndrome measured using the Korean health insurance claims database. Clin Exp Rheumatol. 2020;38(Suppl 126):40\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"470_CR32","first-page":"459","volume":"40","author":"K Aozasa","year":"1990","unstructured":"Aozasa K. Hashimoto\u2019s thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn. 1990;40(7):459\u201368.","journal-title":"Acta Pathol Jpn"},{"key":"470_CR33","doi-asserted-by":"publisher","first-page":"937871","DOI":"10.3389\/fendo.2022.937871","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Wang X, Liang Y, et al. Cancer risk in hashimoto\u2019s thyroiditis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:937871.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"470_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174\u201380.","journal-title":"Autoimmun Rev"},{"key":"470_CR35","doi-asserted-by":"publisher","first-page":"904682","DOI":"10.3389\/fimmu.2022.904682","volume":"13","author":"J Deng","year":"2022","unstructured":"Deng J, Liu M, Xiao R, et al. Risk, incidence, and mortality of breast cancer in primary sj\u00f6gren\u2019s syndrome: A systematic review and Meta-Analysis. Front Immunol. 2022;13:904682.","journal-title":"Front Immunol"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00470-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00470-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:12:21Z","timestamp":1781604741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42358-025-00470-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00470-7","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethics committee under the number 2.930.715 (CAAE 99071018.3.1001.5071), on October 01, 2018, and all patients provided written consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}